Ocular disorders associated with PCSK9 inhibitors: A pharmacovigilance disproportionality analysis.

Published in: British journal of clinical pharmacology (2022)

This pharmacovigilance study identified a possible signal of ocular disorders associated with PCSK9 inhibitors and encourages paying attention to at-risk populations in PCSK9 inhibitors medication.

Keyphrases

adverse drug
low density lipoprotein
healthcare
drug induced
working memory
emergency department
electronic health record
genetic diversity
data analysis